The high cost of funding in Nigeria is threatening the execution of projects by healthcare companies, pushing them into a liquidity crisis as they scramble for cheap funds, BusinessDay’s findings reveal.
High interest rates have led more pharmaceutical companies, diagnostics firms, and even hos
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
